Physician profile
Mark T Mikinski
NPI 1467418897
$12,835.21
in general payments reported to CMS, 2019-2025
35 companies · $1,784 in 2025
The $1,784 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,811 · 2020: $2,251 · 2021: $1,810 · 2022: $1,654 · 2023: $1,910 · 2024: $1,615 · 2025: $1,784.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,300 · Education: $9.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,299.88 |
| Education | $9.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,075.52 | 2021-2025 | Corevalve Evolut R, Cobalt Dr Mri Surescan, Micra |
| Medtronic Vascular, INC. | $2,781.19 | 2019-2020 | |
| Boston Scientific Corporation | $1,745.11 | 2020-2025 | Watchman Access System, Watchman Flx, Watchman |
| Novartis Pharmaceuticals Corporation | $853.18 | 2019-2025 | |
| Pfizer INC. | $610.82 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $557.51 | 2021-2025 | Verquvo, Capvaxive |
| Astrazeneca Pharmaceuticals LP | $501.83 | 2019-2025 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $489.32 | 2021-2025 | Camzyos, Eliquis |
| Amgen INC. | $376.38 | 2019-2025 | Repatha, Repatha |
| Abiomed | $309.54 | 2019-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $243.62 | 2020-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $243.10 | 2019-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $160.38 | 2019-2025 | Jardiance |
| Regeneron Healthcare Solutions, INC. | $134.11 | 2019-2024 | Evkeeza |
| Amarin Pharma, INC. | $97.58 | 2020-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $75.14 | 2021-2022 | |
| Stryker Corporation | $72.46 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Gilead Sciences, INC. | $44.33 | 2019 | |
| Sanofi-Aventis U.S. LLC | $42.78 | 2019 | |
| Esperion Therapeutics, INC. | $41.89 | 2021 | |
| Shockwave Medical, INC | $39.92 | 2025 | |
| Bardy Diagnostics, INC. | $37.48 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $35.28 | 2021 | |
| Kestra Medical Technology Services, INC. | $33.66 | 2025 | Assure Wcd |
| Amryt Pharma Holdings LTD | $32.08 | 2020-2021 | |
| Philips North America LLC | $30.84 | 2024 | (Ao0) Igt Devices Intracardiac |
| Akcea Therapeutics, INC. | $23.27 | 2021 | |
| Abbott Laboratories | $22.86 | 2025 | Perclose Prostyle |
| Astellas Pharma US INC | $22.20 | 2020 | |
| Lexicon Pharmaceuticals, INC. | $21.48 | 2023 | Inpefa |
| Cardiva Medical, INC. | $19.86 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $19.07 | 2023 | Arcalyst |
| Infobionic, INC | $16.95 | 2020 | |
| Novo Nordisk INC | $14.47 | 2023 | Ozempic, Rybelsus |
| Penumbra, INC. | $10.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Mikinski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.